SCHEMBL6540951

SCHEMBL6540951

O=[N+]([O-])c1ccc(Cl)c(CN2C[C@@H]3CCCN3[C@H](C(c3ccccc3)c3ccccc3)C2)c1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
LMNA P02545 3/20 0.51
KDM4E B2RXH2 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.47
TACR1 P25103 1/20 0.45
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C19 P33261 2/20 0.41
CCR2 P41597 1/20 0.40
MAPT P10636 4/20 0.38
TDP1 Q9NUW8 2/20 0.38
ACHE P22303 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
MAPK1 P28482 2/20 0.36
PKM P14618 1/20 0.36
RAB9A P51151 1/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7196051 1.00 ALDH1A1 (0.51) ALDH1A1LMNAKDM4ESMN1; SMN2TACR1
SCHEMBL7196054 1.00 ALDH1A1 (0.51) ALDH1A1LMNAKDM4ESMN1; SMN2TACR1
Hydrochloric Acid SCHEMBL7196904 0.82 TACR1 (0.49) ALDH1A1LMNAKDM4ESMN1; SMN2TACR1
Hydrochloric Acid SCHEMBL7196897 0.82 TACR1 (0.49) ALDH1A1LMNAKDM4ESMN1; SMN2TACR1
Hydrochloric Acid SCHEMBL6541027 0.82 TACR1 (0.49) ALDH1A1LMNAKDM4ESMN1; SMN2TACR1
SCHEMBL7200079 0.81 FFAR1 (0.44) MEN1KMT2AGAA
SCHEMBL6541058 0.81 FFAR1 (0.44) MEN1KMT2AGAA
SCHEMBL7200082 0.81 FFAR1 (0.44) MEN1KMT2AGAA
SCHEMBL7195533 0.79 SIGMAR1 (0.48) ALDH1A1KDM4ECYP1A2CYP2D6CYP2C19
SCHEMBL7195537 0.79 SIGMAR1 (0.48) ALDH1A1KDM4ECYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6787543-B2 PREPARATION OF TACHYKININ ANTAGONISTS; SUBSTITUTED NITROGEN-CONTAINING HETEROCYCLES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-09-07 US disclosed
US-20030176430-A1 Benzhydryl derivatives ASTELLAS PHARMA INC. (JP) 2003-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176430-A1 Benzhydryl derivatives BDKRB1, BDKRB2, TACR1 ALDH1A1 2029/4885LMNA 3930/4885KDM4E 3697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.